Skip Nav Destination
First Edition
Research Article October 4 2024
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT
Research Article October 4 2024
The common, VTE-protective, G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding
Matthew Christopher Sims,Magdalena Gierula,Jonathan C. Stephens,Alex Tokolyi,Luca Stefanucci,Elodie Persyn,Luanluan Sun,Janine H Collins,Emma Davenport,Emanuele Di Angelantonio,Kate Downes,Michael Inouye,Dirk S Paul,William Thomas,Alexander Tolios,NIHR BioResource,Willem H Ouwehand,Nicholas S Gleadall,James T.B. Crawley,Adam S Butterworth,Mattia Frontini,Josefin Ahnstrom
Research Article September 30 2024
OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL
Yuliya Linhares,Cesar O. Freytes,Mohamad Cherry,Carlos Bachier,Michael B Maris,Daanish Hoda,Juan Carlos Varela,Courtney Bellomo,Scott Cross,James H Essell,Suzanne Fanning,Howard Terebelo,Habte A. Yimer,Jay Courtright,Jeff P. Sharman,Ana Kostic,Min Vedal,Ken Ogasawara,Ariel Avilion,Ricardo Espinola,Brenda Yuan,Bassam Mattar
Research Article September 30 2024
Measurable Residual Disease Monitoring in AML With FLT3-ITD Treated With Intensive Chemotherapy Plus Midostaurin
Frank G. Rücker,Lars Bullinger,Sibylle Cocciardi,Sabrina Skambraks,Tamara J Luck,Daniela Weber,Julia Krzykalla,Ema Pozek,Isabelle Janina Schneider,Andrea Corbacioglu,Verena I. Gaidzik,Annika Meid, Dr.,Sophia Aicher,Frank Stegelmann,Anika Schrade,Frauke Theis,Walter Fiedler,Helmut R. Salih,Gerald G. Wulf,Hans J Salwender,Thomas Schroeder,Katharina S Götze,Michael W.M. Kühn,Michael Lübbert,Richard F. Schlenk,Axel Benner,Felicitas R. Thol,Michael Heuser,Arnold Ganser,Hartmut Döhner,Konstanze Döhner
Research Article September 30 2024
Immune reconstitution and evolution of B cell stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL.
Review Article September 30 2024
Quadruplet regimens for patients with newly diagnosed multiple myeloma: A systematic review and meta-analysis
Research Article September 30 2024
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies
Research Article September 30 2024
Peripheral human red blood cell development in human immune system mouse model with heme oxygenase-1 deficiency
Letter September 30 2024
Febrile Neutropenia in Patients with Duffy-null Associated Neutrophil Counts and Multiple Myeloma or AL amyloidosis
Research Article September 30 2024
CD37 in acute myeloid leukemia: a novel surface target for drug delivery
Erin Jeremy,Esthela Artiga,Sara Elgamal,Carolyn M Cheney,Dalen Eicher,Kevan Zalponik,Shelley Orwick,Hsiao-Yin Charlene Charlene Mao,Ronni Wasmuth,Bonnie K Harrington,Allison Mustonen,Peter Beshay,Patrick Halley,Carlos Castro,Katie E Williams,Zachary A Hing,Timothy L Chen,Christopher R Lucas,Nicholas J Vantangoli,Rosa Lapalombella,Nicole Renee Grieselhuber,Xiaokui M. Mo,Erin Hertlein,Natarajan Muthusamy,Bethany L Mundy-Bosse,John C. Byrd,Karilyn Larkin
Research Article September 26 2024
EASIX and m-EASIX Predict CRS and ICANS in Pediatric and AYA Patients post CD19-CAR T cell Therapy
Research Article September 25 2024
Transformation in Marginal Zone Lymphoma: Results from a Prospective Cohort and a Meta-Analysis of the Literature
Côme Bommier,Brian L Link,Brianna J Gysbers,Matthew J Maurer,Melissa C Larson,Arushi Khurana,Yucai Wang,Carrie A Thompson,Dai Chihara,Juan Pablo Alderuccio,Jean L Koff,Narendranath Epperla,Annarita Conconi,Izidore S Lossos,Grzegorz S. Nowakowski,Andrew L Feldman,Thomas M Habermann,Rebecca L King,James R Cerhan
Research Article September 25 2024
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia
Research Article September 25 2024
Outcomes in Children with Provoked Venous Thrombosis and Antiphospholipid Antibodies: Findings from the Kids-DOTT Trial
Letter September 24 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Paul G Kemps,F.J. Sherida H. Woei-A-Jin,Koen D. Quint,Cor van den Bos,Leonie Naeije,Jan AM van Laar,Isabelle Vanden Bempt,Marco J. Koudijs,Ruben Harmen Paul Vorderman,Ellen Stelloo,Joost F Swennenhuis,Annette H Bruggink,Konnie M. Hebeda,Marijn A. Scheijde-Vermeulen,Gilles FH Diercks,Robert M. Verdijk,Patty M Jansen,Esther Hauben,Thomas Tousseyn,Arjen HG Cleven,Tom van Wezel,Astrid G.S. van Halteren,Pancras C.W. Hogendoorn
Research Article September 24 2024
Predictors of Liver Disease Outcomes in Individuals with Hemophilia and HCV Infection
Research Article September 23 2024
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms
Neval Ozkaya,Sarah Melloul Benizri,Girish Venkataraman,Laszlo J Karai,sylvie Fraitag,Jérome Razanamahery,Stefania Pittaluga,Maxime Battistella,Svetalana Pack,François Le Pelletier,Liqiang Xi,Anne Moreau,Ina Lee,Zofia Hélias-Rodzewicz,Jean Donadieu,Julien Haroche, MD, PhD,Mark Raffeld,Elaine S Jaffe,Jean-Francois Emile
Research Article September 23 2024
Real world impact of emicizumab & immunosuppression on Acquired Hemophilia A: A Multicenter US Cohort
Letter September 23 2024
Guidelines are needed to advance health equity in hematology
Research Article September 18 2024
Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML
Research Article September 18 2024
Magrolimab Plus Rituximab with/without Chemotherapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Research Article September 18 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE
Vincent Camus,Mathieu Viennot,Pierre-Julien Viailly,Fanny Drieux,Elena-Liana Veresezan,Victor Bobée,Vinciane Rainville,Elodie Bohers,Pierre Sesques,Corinne Haioun,Eric Durot,Michael Bayaram,Cédric Rossi,Laurent Martin,Dominique Penther,Sophie Kaltenbach,Julie Bruneau,Jérôme Paillassa,Olivier Tournilhac,Nicolas Gower,Alexandre Willaume,Chloe Antier,Loïc Renaud,Emilie Leveque,Pierre Decazes,Stéphanie Becker,David Tonnelet,Philippe GAULARD,Hervé Tilly,Thierry Molina,Alexandra Traverse-Glehen,Marie Donzel,Philippe Ruminy,Fabrice Jardin
Research Article September 18 2024
Asymptomatic multicentric Castleman disease: A potential early stage of idiopathic MCD
Lu Zhang,Qin-hua Liu,Hui Zhou, Prof.,Hui-lai Zhang,Yu-jun Dong,Xiao-bo Wang,Lu-qun Wang,Li-ping Su,Xiao-jing Yan,Yan Li,Ming-Zhi Zhang,Kai-yang Ding,Hui-han Wang,Hong-ling Peng,Li-ye Zhong,Lin Yang,Lin-tao Bi,Da Gao,Guang-xun Gao,Liang Huang,Chun-Yan Sun,Jia Song,Wenbin Qian,Wen-rong Huang,Zhen-ling Li,Yao Liu,Jian Li
Research Article September 18 2024
Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis
Discussion September 12 2024
Point-of-Care CAR-T Manufacturing Solutions: Can One Model Fit All?
Research Article September 12 2024
Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation
Research Article September 12 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy
Jad Othman,Angela Hwang,Maximillian Hugo Brodermann,Islam Abdallah,Kayleigh McCloskey,Paolo Gallipoli,Georgina Clarke,Raymond Dang,Jennifer Vidler,Pramila Krishnamurthy,Faisal Basheer,Anne-Louise Latif, Dr,Renuka Palanicawandar,Tom Taylor,Asra Khan,Victoria Campbell,Francesca Hogan,Alexandros Kanellopoulos,Kathryn Fleming,Angela Collins,Christopher Dalley,Justin Loke,Scott Marshall,David Taussig,Sreetharan Munisamy,Eleana Loizou,Heba Yassin,Mike Dennis,Rui Zhao,Edward Belsham,Duncan Murray,Nicole Fowler,Jenny O'Nions, Dr,Anjum Bashir Khan,Rob S. Sellar,Richard James Dillon
Research Article September 9 2024
A Multicenter Phase II Clinical Trial of Low-Dose Subcutaneous Decitabine in Myelofibrosis
Research Article September 3 2024
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer associated fibroblasts
Research Article September 3 2024
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice
Research Article September 3 2024
Ibrutinib plus rituximab and mini-CHOP in very elderly patients with newly diagnosed DLBCL: A phase II ALLG study
Research Article August 30 2024
Local Radiation Enhances Systemic CAR T Cell Efficacy by Augmenting Antigen Cross-Presentation and T-cell Infiltration
Research Article August 30 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study
Simon Renders,Maud Ngoya,Herve Finel,Marie-Thérèse Rubio,William M Townsend,Roland Schroers,Urban Novak,Nicolaas Schaap,Mahmoud Aljurf,Grzegorz Helbig,Matthew Collin,Guido Kobbe,Huynh Anne,José Antonio Antonio Pérez-Simón,Adrian Bloor,Hervé Ghesquieres,Anna Sureda,Norbert Schmitz,Bertram Glass,Peter Dreger
Research Article August 30 2024
Magrolimab Plus Rituximab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Phase 1/2 Trial 3-Year Follow-up
Research Article August 30 2024
Evaluation of prognostic factors for high-risk classical Hodgkin lymphoma undergoing autologous transplantation
Narendranath Epperla,Ying Huang,Amanda F Cashen,John L Vaughn,Walter Hanel,Talha Badar,Stefan K Barta,Paolo F. Caimi,Tarsheen K Sethi,Nishitha Reddy,Reem Karmali,Celeste Bello,Julio C. Chavez,Shalin K. Kothari,Francisco J. Hernandez-Ilizaliturri,Jakub Svoboda,Frederick Lansigan,Martha J Glenn,Jonathon B Cohen,Caryn Sorge,Beth Christian,Alex F. Herrera,Mehdi Hamadani,Luciano J. Costa,Ana C Xavier
Letter August 29 2024
